Journal Article

A protocol for a randomized controlled trial investigating the safety and cost-effectiveness of outpatient total hip arthroplasty

Bryant, Dianne M., Marsh, Jacquelyn D., Lanting, Brent A., Zomar, Bryn O.

2020

Overview

Background A significant proportion of the overall cost of total hip arthroplasty (THA) results from the inpatient hospital stay following the procedure. Considering the substantial and increasing number of these procedures performed annually, shifting to an outpatient model of care where the patient is discharged home the same day as their surgery represents a potential for significant cost savings. The potential significant impact of an outpatient care model on constrained healthcare budgets and lack of high-quality evidence regarding its effectiveness warrants a rigorous comparative trial. The purpose of this prospective, randomized controlled trial is to evaluate outpatient care pathways for THA. Specifically, our objectives are to compare the rate of serious adverse events and estimate the cost-effectiveness of outpatient compared to standard inpatient THA. Methods We will include patients undergoing primary THA whom have an American Society of Anaesthetists status equal to or less than three, live within a 60-min driving distance of the institution and have an adult to accompany them home postoperatively and stay with them overnight. Consenting patients will be randomized to be discharged on the same day as surgery, as outpatients, or as inpatients according to standard of care (minimum of one night in hospital) using a modified Zelen consent model. The primary outcome measure is the incidence of serious adverse events at 30 days postoperative. Participants and their caregivers will complete secondary outcomes measures at each follow-up visit including patient-reported outcome measures and self-reported cost questionnaires. Discussion This protocol is the first randomized trial to use blinding to evaluate outpatient THA compared to standard overnight stay and first to prospectively perform a full economic evaluation. It is also the first adequately powered trial to prospectively assess the safety of outpatient THA. Successful completion of this study could have the potential to provide clinical evidence for the role of outpatient THA in current practice. Trial registration This study was retrospectively registered on ClinicalTrials.gov ( NCT03026764 ) on March 9th, 2016.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Adult / Arthritis / Arthroplasty, Replacement, Hip - adverse effects / Caregivers / Comparative analysis / Cost analysis / Cost control / Cost-Benefit Analysis / Cost-effect / Economic aspects / Emergency medical care / Epidemiology / Health care costs / Health economics / Hip / Hip replacement arthroplasty / Humans / Internal Medicine / Investigations / Joint replacement surgery / Joint surgery / Length of Stay / Medical care quality / Medicine / Medicine & Public Health / Musculoskeletal diseases / Orthopedics / Orthopedics and biomechanics / Osteoarthritis / Outpatient / Outpatient care facilities / Outpatients / Pain management / Patient satisfaction / Patients / Prospective Studies / Quality of life / Randomized Controlled Trials as Topic / Rehabilitation / Rheumatology / Same day discharge / Sports Medicine / Study Protocol / Surgery / Total hip arthroplasty / Validation studies / Zelen